1Mizuno Y, Yoshimura M, Nakayama M, et al. Secretion patterns of A-type and B-type natrluretic peptides in patients with hypertrophic cardiomyopathy or dilated cardiomyopathy [J]. Circulation, 2000, 102 (suppl 2):504.
2Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide (BNP)in the diagnosis of CHF in an urgent care setting[J]. J Am Coll Cardiol,2003,37:379-385.
3Cheng VL, Krishnzswamy P, Kazaegra R, et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure[J].J Am Coll Cardiol,2001,37:386-391.
5ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult[J].Circulation,2005,112(4):e154-235.
6Morrison LK,Harrison A,Krishnaswamy P,et al.Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea[J].J Am Coll Cardiol,2002,39(2):202-209.
7Maeda K,Tsutamoto T,Wada A,et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction[J].Am Heart J,1998,135(5 Pt 1):825-832.
